Fibrinolytic activity and platelet function in subjects with obstructive sleep apnoea and a patent foramen ovale: Is there an option for prevention of ischaemic stroke?

Stroke Research and Treatment

Volumn , Issue , 2012, Pages

  Reggiani, Monica ^a,b   Karttunen, Vesa ^a   Wartiovaara Kautto, Ulla ^c   Riutta, Asko ^d   Uchiyama, Shinichiro ^e   Hillbom, Matti ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; 2,3 DINORTHROMBOXANE B2; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBRINOLYSIS; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICHANNEL RECORDER; NIGHT SLEEP; OXIMETRY; PATENT FORAMEN OVALE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; URINARY EXCRETION;

EID: 84870197206     PISSN: None     EISSN: 20420056     Source Type: Journal    
DOI: 10.1155/2012/945849     Document Type: Article

References (37)

1. Caples S. M., Gami A. S., Somers V. K., Obstructive sleep apnea. Annals of Internal Medicine 2005 142 3 187 197 2-s2.0-13244259597 (Pubitemid 40189111)
2. Yaggi H., Mohsenin V., Obstructive sleep apnoea and stroke. Lancet Neurology 2004 3 6 333 342 2-s2.0-2442511744 10.1016/S1474-4422(04)00766-5 (Pubitemid 38648854)
3. Yaggi H. K., Concato J., Kernan W. N., Lichtman J. H., Brass L. M., Mohsenin V., Obstructive sleep apnea as a risk factor for stroke and death. The New England Journal of Medicine 2005 353 19 2034 2041 2-s2.0-27744474299 10.1056/NEJMoa043104 (Pubitemid 41609096)
4. Mohsenin V., Sleep-related breathing disorders and risk of Stroke. Stroke 2001 32 6 1271 1276 2-s2.0-0034982934 (Pubitemid 32530406)
5. Wolk R., Kara T., Somers V. K., Sleep-disordered breathing and cardiovascular disease. Circulation 2003 108 1 9 12 2-s2.0-0037489291 10.1161/01.CIR.0000072346.56728.E4 (Pubitemid 36859012)
6. Gami A. S., Pressman G., Caples S. M., Kanagala R., Gard J. J., Davison D. E., Malouf J. F., Ammash N. M., Friedman P. A., Somers V. K., Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004 110 4 364 367 2-s2.0-3342988234 10.1161/01.CIR.0000136587.68725.8E (Pubitemid 38993843)
7. Von Känel R., Dimsdale J. E., Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 2003 124 5 1956 1967 2-s2.0-10744229839 10.1378/chest.124.5.1956 (Pubitemid 37433597)
8. Petty G. W., Khandheria B. K., Meissner I., Whisnant J. P., Rocca W. A., Christianson T. J. H., Sicks J. D., O'Fallon W. M., McClelland R. L., Wiebers D. O., Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clinic Proceedings 2006 81 5 602 608 2-s2.0-33646405196 10.4065/81.5.602
9. Karttunen V., Ventilä M., Ikäheimo M., Niemelä M., Hillbom M., Ear oximetry: a noninvasive method for detection of patent foramen ovale: a study comparing dye dilution method and oximetry with contrast transesophageal echocardiography. Stroke 2001 32 2 448 453 2-s2.0-0035134438 (Pubitemid 32155233)
10. Hassell K. L., Hematologic ramifications of patent foramen ovale-role of hypercoagulable state. Cardiology Clinics 2005 23 1 65 71 2-s2.0-12844261070 10.1016/j.ccl.2004.10.002 (Pubitemid 40164801)
11. Berthet K., Lavergne T., Cohen A., Guize L., Bousser M. G., Le Heuzey J. Y., Amarenco P., Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000 31 2 398 403 2-s2.0-0033980196 (Pubitemid 30078172)
12. Brogren H., Karlsson L., Andersson M., Wang L., Erlinge D., Jern S., Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 2004 104 13 3943 3948 2-s2.0-10244249152 10.1182/blood-2004-04-1439 (Pubitemid 39620142)
13. Lijnen H. R., Pleiotropic functions of plasminogen activator inhibitor-1. Journal of Thrombosis and Haemostasis 2005 3 1 35 45 2-s2.0-18844375381 10.1111/j.1538-7836.2004.00827.x (Pubitemid 41647113)
14. Uchiyama T., Kurabayashi M., Ohyama Y., Utsugi T., Akuzawa N., Sato M., Tomono S., Kawazu S., Nagai R., Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 4 1155 1161 2-s2.0-0034032489 (Pubitemid 30207596)
15. Ruggeri Z. M., Orje J. N., Habermann R., Federici A. B., Reininger A. J., Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006 108 6 1903 1910 2-s2.0-33748704252 10.1182/blood-2006-04- 011551 (Pubitemid 44394999)
16. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension 2003 21 11 1983 1992 2-s2.0-0344718782 10.1097/00004872-200311000- 00002 (Pubitemid 38296854)
17. Fukuyama M., Sakai K., Itagaki I., Kawano K., Murata M., Kawai Y., Watanabe K., Handa M., Ikeda Y., Continuous measurement of shear-induced platelet aggregation. Thrombosis Research 1989 54 3 253 260 2-s2.0-0024315819 (Pubitemid 19140515)
18. Uchiyama S., Yamazaki M., Maruyama S., Handa M., Ikeda Y., Fukuyama M., Itagaki I., Shear-induced platelet aggregation in cerebral ischemia. Stroke 1994 25 8 1547 1551 2-s2.0-0028059351 (Pubitemid 24233956)
19. Numminen H., Kobayashi M., Uchiyama S., Iwata M., Ikeda Y., Riutta A., Syrjälä M., Kekomäki R., Hillbom M., Effects of alcohol and the evening meal on shear-induced platelet aggregation and urinary excretion of prostanoids. Alcohol and Alcoholism 2000 35 6 594 600 2-s2.0-0033666772
20. Rångemark C., Hedner J. A., Carlson J. T., Gleerup G., Winther K., Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 1995 18 3 188 194 2-s2.0-0028901241
21. von Känel R., Loredo J. S., Ancoli-Israel S., Dimsdale J. E., Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep and Breathing 2006 10 3 139 146 2-s2.0-33748333111 10.1007/s11325-006-0060-3 (Pubitemid 44322495)
22. Vaughan D. E., PAI-1 and atherothrombosis. Journal of Thrombosis and Haemostasis 2005 3 8 1879 1883 2-s2.0-28344445503 10.1111/j.1538-7836.2005. 01420.x (Pubitemid 41716575)
23. Haapaniemi E., Tatlisumak T., Soinne L., Syrjälä M., Kaste M., Plasminogen activator inhibitor-1 in patients with ischemic stroke. Acta Neurochirurgica 2000 76 277 278 2-s2.0-0034570654
24. Wessendorf T. E., Thilmann A. F., Wang Y. M., Schreiber A., Konietzko N., Teschler H., Fibrinogen levels and obstructive sleep apnea in ischemic stroke. American Journal of Respiratory and Critical Care Medicine 2000 162 6 2039 2042 2-s2.0-0034520051 (Pubitemid 32051660)
25. Thögersen A. M., Jansson J. H., Boman K., Nilsson T. K., Weinehall L., Huhtasaari F., Hallmans G., High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998 98 21 2241 2247 2-s2.0-0032564442 (Pubitemid 28533841)
26. Krieger J., Benzoni D., Sforza E., Sassard J., Urinary excretion of prostanoids during sleep in obstructive sleep apnoea patients. Clinical and Experimental Pharmacology and Physiology 1991 18 8 551 555 2-s2.0-0025821052
27. Kimura H., Niijima M., Abe Y., Edo H., Sakabe H., Kojima A., Hasako K., Masuyama S., Tatsumi K., Kuriyama T., Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome. Internal Medicine 1998 37 2 127 133 2-s2.0-0031989376 (Pubitemid 128520828)
28. Bokinsky G., Miller M., Ault K., Husband P., Mitchell J., Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995 108 3 625 630 2-s2.0-0029155669
29. Eisensehr I., Ehrenberg B. L., Noachtar S., Korbett K., Byrne A., McAuley A., Palabrica T., Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 1998 51 1 188 195 2-s2.0-0031814516 (Pubitemid 28345382)
30. Geiser T., Buck F., Meyer B. J., Bassetti C., Haeberli A., Gugger M., In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002 69 3 229 234 2-s2.0-0036311873 10.1159/000063625 (Pubitemid 34827837)
31. Hui D. S., Ko F. W., Fok J. P., Chan M. C., Li T. S., Tomlinson B., Cheng G., The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004 125 5 1768 1775 2-s2.0-2442421740 10.1378/chest.125.5.1768 (Pubitemid 38648410)
32. Sanner B. M., Konermann M., Tepel M., Groetz J., Mummenhoff C., Zidek W., Platelet function in patients with obstructive sleep apnoea syndrome. European Respiratory Journal 2000 16 4 648 652 2-s2.0-0033777550 10.1034/j.1399-3003. 2000.16d14.x
33. West S., Segal H., Harrison P., Stradling J., Platelet function (measured by Platelet Function Analyser-100) and obstructive sleep apnoea. Journal of Sleep Research 2005 14 3 325 327 2-s2.0-24744455629 10.1111/j.1365-2869.2005. 00469.x (Pubitemid 41291319)
34. Beelke M., Angeli S., Del Sette M., De Carli F., Canovaro P., Nobili L., Ferrillo F., Obstructive sleep apnea can be provocative for right-to-left shunting through a patent foramen ovale. Sleep 2002 25 8 856 862 2-s2.0-0037114782 (Pubitemid 35424528)
35. Shanoudy H., Soliman A., Raggi P., Liu J. W., Russell D. C., Jarmukli N. F., Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 1998 113 1 91 96 2-s2.0-0031963545 (Pubitemid 28044930)
36. Lavie L., Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Medicine Reviews 2003 7 1 35 51 2-s2.0-0037316130 10.1053/smrv.2002.0261 (Pubitemid 36188305)
37. Guchlerner M., Kardos P., Liss-koch E., Franke J., Wunderlich N., Bertog S., Sievert H., PFO and right-to-left shunting in patients with obstructive sleep apnoea. Journal of Clinical Sleep Medicine 2012 8 375 380